Lizzy Rosser
@bcellsrosser.bsky.social
160 followers 150 following 56 posts
Interested in all things B cells, autoimmunity, nutritional immunology and child health. Located at UCL, ARR department in Division of Medicine.
Posts Media Videos Starter Packs
bcellsrosser.bsky.social
Such an important topic - especially in terms of impact on the immune system. Glad that we have @emmaschambers.bsky.social on the case!
bcellsrosser.bsky.social
Plasma cell is the only right answer.
britsocimm.bsky.social
Our iconic immune cell badges are back for #BSI25, and you get to choose the next design! 🎨🧫

Vote now and help decide which badge will join the line-up in Liverpool 👇

Cast your vote here🔗: https://bit.ly/46DtHzy
Reposted by Lizzy Rosser
diniscalado.bsky.social
New preprint from the lab! Lactate, a tumor-derived metabolite, blocks B cells from entering tumors and forming tertiary lymphoid structures (TLSs). Congratulations Victoire Boulat - in a great collaboration with Anita Grigoriadis! tinyurl.com/3vvk9kec #Immunology #TLS #CancerMetabolism #Bcells
Reposted by Lizzy Rosser
medresfdn.bsky.social
Selena Gomez has shared her experiences living with #lupus since 2015 - writes Foundation-funded researcher @bcellsrosser.bsky.social for @uk.theconversation.com.

To learn more, you can meet Dr Lizzy Rosser at our New Scientist Live stand (C20) on 18-19 October! shorturl.at/BusFG
bcellsrosser.bsky.social
Congratulations to our new @fightforsight.bsky.social PhD student Persephone Jenkins (3 days in!) for talking at her first PPIE event today. We are very lucky that Seph will be joining us for four years working on childhood uveitis, B cells and the microbiome 👀
Reposted by Lizzy Rosser
Reposted by Lizzy Rosser
acr-journals.bsky.social
Nested cohort study within UCAN CAN-DU estimated effect of time from symptom onset to start of biologic in JIA. Early start of biologic therapies in JIA was assoc. w/ higher proportion of patients reaching inactive arthritis within 6 months

Arthritis & Rheumatology
doi.org/10.1002/art....

#Medsky
Proportion of Juvenile Idiopathic Arthritis patients reaching inactive arthritis (active joint count = 0) after six months of early biologic treatment compared to intermediate and late biologic treatment. Proportion of JIA patients reaching inactive arthritis after six months of biologic treatment across three treatment groups: early treatment group (time from symptom onset to biologic start: 0-6 months), intermediate treatment group (7-12 months), and late treatment group (13-24 months). Inactive arthritis was defined as having an active joint count of zero at six months
bcellsrosser.bsky.social
Looking forward to watching this later!
arrdept-ucldom.bsky.social
Congratulations 🥳 to Prof Ciurtin @ciurtinlab.bsky.social who will deliver the 2025 Lady Estelle Wolfson Lecture in Translational Medicine at the Royal College of Physicians today! Coziana will focus on improving risk stratification and management of cardiovascular risk in young people with lupus.
bcellsrosser.bsky.social
I am so excited to be contributing to the upcoming ‘Medicine at the Crick Event’ @crick.ac.uk… organised by Prof Vinuesa and Prof Lee.. come and join us for what will be a fantastic discussion… @arrdept-ucldom.bsky.social

www.crick.ac.uk/whats-on/med...
Medicine at the Crick | New insights and breakthroughs in autoimmunity
www.crick.ac.uk
Reposted by Lizzy Rosser
britsocimm.bsky.social
⏰ Abstract deadline TOMORROW!

The BSI West of Scotland Immunology Group showcase on Thursday 2 October will feature cutting-edge talks on T cell immunometabolism + helminth immunity, plus the 10th Delphine Parrott memorial lecture. #BSIWSIG25

Submit now 👉 https://bit.ly/4npHBe2
bcellsrosser.bsky.social
Wooo! So exciting to see our new department building up its reputation slowly…!
arrdept-ucldom.bsky.social
We now have over 600 followers! Hello everyone from our new UCL department! Give some of our members a follow when you have a chance (we’ll post the in the thread below!) and stay tuned for our research updates 🧬 🎇 😃
Reposted by Lizzy Rosser
thelisterinstitute.bsky.social
Amazing to see so much excellent science conducted over the summer through out Summer Studentship scheme. Congrats to Nina, hopefully just the first of many poster sessions to come...
bcellsrosser.bsky.social
Congratulations to our @thelisterinstitute.bsky.social BSc summer student Nina Bird on her first conference poster presentation at the Lister Institute’s Annual Conference 🎇 Nina has been a joy to have in the lab on this fab scheme!
Reposted by Lizzy Rosser
madhvimenon.bsky.social
🔔 Fantastic opportunities to join us as part of the new and exciting @exposomeimmunology.bsky.social
@lydiabeckeriii.bsky.social

Check out the details 👇

Please spread the word! #immunosky
exposomeimmunology.bsky.social
WE ARE HIRING! www.manchester.ac.uk/exposome-jobs

Vacancies inc. 3x PDRA positions, 2x data scientists and a Transition Fellowship in Air Pollution.

Join us as we embark on a 14 year journey to understand how the exposome impacts immune regulation and chronic inflammation.

#hiring #immunosky
bcellsrosser.bsky.social
Congratulations to our @thelisterinstitute.bsky.social BSc summer student Nina Bird on her first conference poster presentation at the Lister Institute’s Annual Conference 🎇 Nina has been a joy to have in the lab on this fab scheme!
bcellsrosser.bsky.social
@merrywilkinsonlab.bsky.social is on BlueSky! Give her a follow now!!!
merrywilkinsonlab.bsky.social
Honoured this JDM family were willing to share their experiences and are enthusiastic about our research. A massive thanks to all the authors, extended team and patients who were part of this research.
uclnews.bsky.social
Children with the rare, debilitating muscle disease juvenile dermatomyositis may benefit from exciting new research by experts including Dr Merry Wilkinson and Professor Wedderburn (UCL Great Ormond Street Institute for Child Health) and at Great Ormond Street Hospital @uclpophealthsci.bsky.social
Reposted by Lizzy Rosser
uclnews.bsky.social
Children with the rare, debilitating muscle disease juvenile dermatomyositis may benefit from exciting new research by experts including Dr Merry Wilkinson and Professor Wedderburn (UCL Great Ormond Street Institute for Child Health) and at Great Ormond Street Hospital @uclpophealthsci.bsky.social
Research breakthrough ‘open doors to new treatments’ for rare muscle disease
Children with a rare, debilitating muscle disease could benefit from the findings of new research by experts at UCL and Great Ormond Street Hospital (GOSH).
www.ucl.ac.uk
Reposted by Lizzy Rosser
dianaematei.bsky.social
And the send-off from the cutest helper tradition continues 🥹
Off I go to Basel for what's hopefully an amazing conference all about mucosal lymphocytes 😍
#EMBObarrierTissues
@bcellsrosser.bsky.social
Reposted by Lizzy Rosser
britsocimm.bsky.social
Do you live with an immunodeficiency or have another immune-related condition like asthma or diabetes, or care for someone who does?

Join our new PPI Network to help shape the future of immunology.

Apply by 22 Sept 2025

🔗 More info: https://bit.ly/3Jz7cT6
Reposted by Lizzy Rosser
thelisterinstitute.bsky.social
We're so pleased to support Lizzy's important work!
bcellsrosser.bsky.social
Thanks @dianaematei.bsky.social - I loved writing this with Prof Wedderburn in @natrevrheum.nature.com on the back of our new departmental launch @arrdept-ucldom.bsky.social
dianaematei.bsky.social
Here's to the new era in rheumatology research!! You have to give this a read it's as thought-provoking as it is exciting 🤩

@bcellsrosser.bsky.social @arrdept-ucldom.bsky.social

www.nature.com/articles/s41...